PerkinElmer Closes Acquisition of Pediatrix's Newborn Screening Business | GenomeWeb
 
NEW YORK (GenomeWeb News) – PerkinElmer said Friday that it has completed its acquisition of the newborn metabolic screening business of Pediatrix Medical Group.
 
The company announced its plans to acquire the business in December in a bid to expand its presence in the neonatal health market.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.